Supranutritional Sodium Selenate Supplementation Delivers Selenium to the Central Nervous System: Results from a Randomized Controlled Pilot Trial in Alzheimer's Disease
- 13 September 2018
- journal article
- research article
- Published by Elsevier in Neurotherapeutics
- Vol. 16 (1) , 192-202
Abstract
No abstract availableKeywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Deakin University
- Australian National Health and Medical Research Council (GNT1138673, GNT1103703, GNT1132604)
- Australian National Health and Medical Research Council (GNT1105784, GNT1122981)
- Velacor Therapeutics
- Agilent Technologies (AU)
- Agilent Technologies (AUS)
This publication has 46 references indexed in Scilit:
- Selenium Toxicity from a Misformulated Dietary Supplement, Adverse Health Effects, and the Temporal Response in the Nail Biologic MonitorNutrients, 2013
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease modelsProceedings of the National Academy of Sciences, 2010
- Acute Selenium Toxicity Associated With a Dietary SupplementArchives of internal medicine (1960), 2010
- Organoselenium (Sel-Plex diet) decreases amyloid burden and RNA and DNA oxidative damage in APP/PS1 miceFree Radical Biology and Medicine, 2009
- Selenium Level and Cognitive Function in Rural Elderly ChineseAmerican Journal of Epidemiology, 2007
- Mitochondrial dysfunction and oxidative stress in neurodegenerative diseasesNature, 2006
- Neurodegenerative diseases and oxidative stressNature Reviews Drug Discovery, 2004
- Assessment of requirements for selenium and adequacy of selenium status: a reviewEuropean Journal of Clinical Nutrition, 2004
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984